BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6446843)

  • 1. Pattern visual evoked potentials in Huntington's disease.
    Rizzo PA; Pierelli F; Pozzessere G; Morocutti C
    Acta Neurol (Napoli); 1980 Apr; 2(2):128-31. PubMed ID: 6446843
    [No Abstract]   [Full Text] [Related]  

  • 2. Error processing in normal aging and in basal ganglia disorders.
    Beste C; Willemssen R; Saft C; Falkenstein M
    Neuroscience; 2009 Mar; 159(1):143-9. PubMed ID: 19166908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Somatosensory and visual evoked potentials in Huntington's chorea].
    Takahashi K; Okada E; Fujitani Y
    Rinsho Shinkeigaku; 1972 Aug; 12(8):381-5. PubMed ID: 4264390
    [No Abstract]   [Full Text] [Related]  

  • 4. Huntington's disease: alterations of visual and somatosensory cortical evoked potentials in patients and offspring.
    Oepen G; Doerr M; Thoden U
    Adv Neurol; 1982; 32():141-7. PubMed ID: 6459718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological measures as potential biomarkers in Huntington's disease: review and future directions.
    Nguyen L; Bradshaw JL; Stout JC; Croft RJ; Georgiou-Karistianis N
    Brain Res Rev; 2010 Sep; 64(1):177-94. PubMed ID: 20381528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentials.
    Beste C; Konrad C; Saft C; Ukas T; Andrich J; Pfleiderer B; Hausmann M; Falkenstein M
    Exp Neurol; 2009 Mar; 216(1):148-57. PubMed ID: 19111540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between evoked potential and neuropsychological findings in persons "at risk" for Huntington's disease.
    Josiassen RC; Curry LM; Mancall EL; Shagass C; Roemer RA
    J Clin Exp Neuropsychol; 1986 Jan; 8(1):21-36. PubMed ID: 2935556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capacity of attention and simultaneous perception of objects: a group study of Huntington's disease patients.
    Finke K; Schneider WX; Redel P; Dose M; Kerkhoff G; Müller HJ; Bublak P
    Neuropsychologia; 2007 Nov; 45(14):3272-84. PubMed ID: 17681560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of the contingent negative variation in Huntington's disease: correlations with clinical features.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    J Neurol Sci; 2007 Mar; 254(1-2):84-9. PubMed ID: 17300807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual (VEP) and somatosensory (SSEP) evoked potentials in Huntington's chorea.
    Oepen G; Doerr M; Thoden U
    Electroencephalogr Clin Neurophysiol; 1981 Jun; 51(6):666-70. PubMed ID: 6165568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatosensory evoked potentials in Huntington's disease.
    Margari L; Specchio LM; Russo M; De Tommaso M; De Liso E; Erriquez MA; Olivieri G; Ferrari E
    Acta Neurol (Napoli); 1985 Oct; 7(5):401-8. PubMed ID: 2932892
    [No Abstract]   [Full Text] [Related]  

  • 12. Evoked potentials in Huntington's disease. A comparative and longitudinal study.
    Ehle AL; Stewart RM; Lellelid NA; Leventhal NA
    Arch Neurol; 1984 Apr; 41(4):379-82. PubMed ID: 6231012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromyographic silent period after transcranial brain stimulation in Huntington's disease.
    Priori A; Berardelli A; Inghilleri M; Polidori L; Manfredi M
    Mov Disord; 1994 Mar; 9(2):178-82. PubMed ID: 8196679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response inhibition in Huntington's disease-a study using ERPs and sLORETA.
    Beste C; Saft C; Andrich J; Gold R; Falkenstein M
    Neuropsychologia; 2008 Apr; 46(5):1290-7. PubMed ID: 18241897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical neurophysiology of aging and dementia.
    Pedley TA; Miller JA
    Adv Neurol; 1983; 38():31-49. PubMed ID: 6225316
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurophysiology in Huntington's disease: an update.
    Mayer IM; Orth M
    Neurodegener Dis Manag; 2014; 4(2):155-64. PubMed ID: 24832033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Event-related potentials (ERPs) and Huntington's disease: dissociation of processing time for auditory and somatosensory modality.
    Van Rijckevorsel-Harmant K
    Acta Neurol Belg; 1989; 89(3-4):317. PubMed ID: 2534262
    [No Abstract]   [Full Text] [Related]  

  • 18. Adult onset myoclonic Huntington's disease.
    Carella F; Scaioli V; Ciano C; Binelli S; Oliva D; Girotti F
    Mov Disord; 1993 Apr; 8(2):201-5. PubMed ID: 8474490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulus-response compatibility in Huntington's disease: a cognitive-neurophysiological analysis.
    Beste C; Saft C; Andrich J; Gold R; Falkenstein M
    J Neurophysiol; 2008 Mar; 99(3):1213-23. PubMed ID: 18184888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emotion recognition in Huntington's disease and frontotemporal dementia.
    Snowden JS; Austin NA; Sembi S; Thompson JC; Craufurd D; Neary D
    Neuropsychologia; 2008 Sep; 46(11):2638-49. PubMed ID: 18533200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.